Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jurema Schmidt

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Chemmedchem|October 25, 2018
Selective Optimization of Pranlukast to Farnesoid X Receptor ModulatorsSimone Schierle, Jurema Schmidt, Astrid Kaiser, et al.
Bioorganic & Medicinal Chemistry|July 21, 2018
Structural optimization and in vitro profiling of N-phenylbenzamide-based farnesoid X receptor antagonistsJurema Schmidt, Simone Schierle, Leonie Gellrich, et al.
ACS Pharmacology & Translational Science|April 16, 2021
Differential Therapeutic Effects of FXR Activation, sEH Inhibition, and Dual FXR/sEH Modulation in NASH in Diet-Induced Obese MiceMoritz Helmstädter, Jurema Schmidt, Astrid Kaiser, et al.
Biochemical Pharmacology|May 27, 2019
A dual farnesoid X receptor/soluble epoxide hydrolase modulator treats non-alcoholic steatohepatitis in miceMd Abdul Hye Khan, Jurema Schmidt, Anna Stavniichuk, et al.
Scientific Reports|October 2, 2015
NSAIDs Ibuprofen, Indometacin, and Diclofenac do not interact with Farnesoid X ReceptorJurema Schmidt, Franca-Maria Klingler, Ewgenji Proschak, et al.
Journal of Medicinal Chemistry|June 24, 2021
Second-Generation Dual FXR/sEH Modulators with Optimized PharmacokineticsMoritz Helmstädter, Astrid Kaiser, Steffen Brunst, et al.
ACS Medicinal Chemistry Letters|February 19, 2021
A New FXR Ligand Chemotype with Agonist/Antagonist SwitchMoritz Helmstädter, Jan Vietor, Jana Sommer, et al.
Journal of Medicinal Chemistry|November 9, 2018
Structure-Based Approach toward Identification of Inhibitory Fragments for Eleven-Nineteen-Leukemia Protein (ENL)David Heidenreich, Moses Moustakim, Jurema Schmidt, et al.
Scientific Reports|May 3, 2018
Allosteric modulation of the farnesoid X receptor by a small moleculeMatthias Gabler, Jan Kramer, Jurema Schmidt, et al.
Communications Chemistry|January 27, 2023
A triple farnesoid X receptor and peroxisome proliferator-activated receptor α/δ activator reverses hepatic fibrosis in diet-induced NASH in micePascal Heitel, Giuseppe Faudone, Moritz Helmstädter, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Chemmedchem|October 25, 2018
Selective Optimization of Pranlukast to Farnesoid X Receptor ModulatorsSimone Schierle, Jurema Schmidt, Astrid Kaiser, et al.
Bioorganic & Medicinal Chemistry|July 21, 2018
Structural optimization and in vitro profiling of N-phenylbenzamide-based farnesoid X receptor antagonistsJurema Schmidt, Simone Schierle, Leonie Gellrich, et al.
ACS Pharmacology & Translational Science|April 16, 2021
Differential Therapeutic Effects of FXR Activation, sEH Inhibition, and Dual FXR/sEH Modulation in NASH in Diet-Induced Obese MiceMoritz Helmstädter, Jurema Schmidt, Astrid Kaiser, et al.
Biochemical Pharmacology|May 27, 2019
A dual farnesoid X receptor/soluble epoxide hydrolase modulator treats non-alcoholic steatohepatitis in miceMd Abdul Hye Khan, Jurema Schmidt, Anna Stavniichuk, et al.
Scientific Reports|October 2, 2015
NSAIDs Ibuprofen, Indometacin, and Diclofenac do not interact with Farnesoid X ReceptorJurema Schmidt, Franca-Maria Klingler, Ewgenji Proschak, et al.
Journal of Medicinal Chemistry|June 24, 2021
Second-Generation Dual FXR/sEH Modulators with Optimized PharmacokineticsMoritz Helmstädter, Astrid Kaiser, Steffen Brunst, et al.
ACS Medicinal Chemistry Letters|February 19, 2021
A New FXR Ligand Chemotype with Agonist/Antagonist SwitchMoritz Helmstädter, Jan Vietor, Jana Sommer, et al.
Journal of Medicinal Chemistry|November 9, 2018
Structure-Based Approach toward Identification of Inhibitory Fragments for Eleven-Nineteen-Leukemia Protein (ENL)David Heidenreich, Moses Moustakim, Jurema Schmidt, et al.
Scientific Reports|May 3, 2018
Allosteric modulation of the farnesoid X receptor by a small moleculeMatthias Gabler, Jan Kramer, Jurema Schmidt, et al.
Communications Chemistry|January 27, 2023
A triple farnesoid X receptor and peroxisome proliferator-activated receptor α/δ activator reverses hepatic fibrosis in diet-induced NASH in micePascal Heitel, Giuseppe Faudone, Moritz Helmstädter, et al.
Pageof 2